Mankind Pharma Limited IPO Review & Recommendations
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelMankind Pharma Limited IPO
April 25, 2023 - April 27, 2023
Closed
Apply with Angel One
Apply with Zerodha
Pre-Apply with Upstox
Mankind Pharma Limited IPO Review
This Company was incorporated in 1991 and was engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas. They operate in Indian pharmaceuticals formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices. They have made efforts to establish “Mankind” as a well-recognized brand in India. It operates 25 manufacturing. Facilities across India. The manufacturing facilities have a total installed capacity of 42.05 billion units per annum and a wide range of dosage forms including, syrups, vials, ampoules, blow-fill seal soft and hard gels, eye drops, and creams.
Mankind Pharma Limited Products and Services
Mankind Pharma ltd India products and Services are manufactured and markets pharmaceuticals. This Company is active in a number of acute and chronic including anti-infectives, gastrointestinal, neuro/CNS, minerals/vitamins/nutrients, and respiratory. They have created 36 brands in their pharmaceutical business. Their domestic sales have exceeded ₹500.00 million individually, and their brands have helped them maintain a significant share of the prescription drug market. They have experienced sustained growth and have consistently outperformed the growth of the IPM.
They joined the consumer healthcare sector by introducing various unique brands in categories such as emergency contraception, antacid powders, vitamin and mineral supplements, and anti-acne products.
Financial Overview
This Company is engaged in manufacturing and marketing healthcare products. It shows good financial performance, and based on recent performance, the issue appears fully priced. An investor may think to apply for this IPO after doing the research.
Frequently Asked Question
Post-issue shareholdings of Mankind Pharma Limited IPO promoters are 76.50%.
You will receive the allotted shares in your Demat account on May 05, 2023.
Pre-issue shareholdings of Mankind Pharma Limited IPO promoters are 79.00%
Price of 1 share of Mankind Pharma Limited IPO is ₹1026 - ₹1080.
Mankind Pharma Limited IPO will get listed on April 08, 2022.
Mankind Pharma Limited IPO shares will get listed at NSE and BSE.
Mankind Pharma Limited IPO will be closed on April 27, 2023.
Market lot size of the Mankind Pharma Limited IPO is 13 shares.
Kfin Technologies Limited is the registrar of Mankind Pharma Limited IPO.
Face value of equity shares of Mankind Pharma Limited IPO is ₹1.
Mankind Pharma Limited IPO is going to open on April 25, 2023.
You can apply for an IPO from any place by using internet as it is an online process. You can apply for an IPO using 2 methods i.e., ASBA and UPI. ASBA facility is provided by your bank and UPI method is offered by your stock broker. You can invest in Mankind Pharma Limited IPO by using any one of these method as per your convenience.
If you do not get the allotment of Global Surfaces shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Comments for Mankind Pharma Limited IPO Review & Recommendations
0 comments